CELLULAR BIOMEDICINE GROUP I's ticker is CBMG and the CUSIP is 15117P102. A total of 76 filers reported holding CELLULAR BIOMEDICINE GROUP I in Q3 2020. The put-call ratio across all filers is 2.38 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $0 | – | 26,210 | +7120.4% | 0.00% | – |
| Q3 2020 | $0 | -100.0% | 363 | -86.3% | 0.00% | – |
| Q4 2019 | $42,000 | +4100.0% | 2,644 | +2570.7% | 0.00% | – |
| Q3 2019 | $1,000 | -96.4% | 99 | -94.2% | 0.00% | – |
| Q2 2019 | $28,000 | -56.9% | 1,704 | -55.2% | 0.00% | – |
| Q1 2019 | $65,000 | +18.2% | 3,803 | +21.7% | 0.00% | – |
| Q4 2018 | $55,000 | +685.7% | 3,125 | +656.7% | 0.00% | – |
| Q3 2018 | $7,000 | +40.0% | 413 | +56.4% | 0.00% | – |
| Q2 2018 | $5,000 | -85.7% | 264 | -86.9% | 0.00% | -100.0% |
| Q1 2018 | $35,000 | +29.6% | 2,022 | -17.4% | 0.00% | +100.0% |
| Q4 2017 | $27,000 | – | 2,448 | +8966.7% | 0.00% | – |
| Q3 2015 | $0 | – | 27 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PLATINUM INVESTMENT MANAGEMENT LTD | 672,885 | $11,123,000 | 0.26% |
| AWM Investment Company, Inc. | 80,165 | $1,325,000 | 0.25% |
| Nikko Asset Management Americas, Inc. | 532,318 | $8,799,000 | 0.17% |
| ARK Investment Management | 314,378 | $5,197,000 | 0.13% |
| Sumitomo Mitsui Trust Holdings, Inc. | 528,418 | $8,735,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 32,100 | $531,000 | 0.01% |
| Mizuho Securities Co. Ltd. | 300 | $5,000 | 0.01% |
| GEODE CAPITAL MANAGEMENT, LLC | 148,815 | $2,459,000 | 0.00% |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 18,629 | $308,000 | 0.00% |
| STATE OF WISCONSIN INVESTMENT BOARD | 16,100 | $237,000 | 0.00% |